Emerging Antibiotic Resistance In Psedomonas And Acinetobacter Strains Isolated From ICU Patients: Comparison Of Years 1999, 2006 And 2009
|
|
- Randolf Ball
- 5 years ago
- Views:
Transcription
1 Article ID: WMC ISSN Emerging Antibiotic Resistance in Psedomonas and Acinetobacter Strains Isolated from ICU Patients: Comparison of Years 1999, 2006 and 2009 Corresponding Author: Dr. Kadriye Kart Yasar, M.D., Haseki Training and Research Hospital,Clinical Microbiology and Infectious Disesases, Turkey Submitting Author: Dr. Kadriye Kart Yasar, M.D., Clinical Microbiology and Infectious Disesases, Haseki Training and Research Hospital, Turkey Article ID: WMC Article Type: Original Articles Submitted on:24-apr-2011, 06:17:17 PM GMT Article URL: Subject Categories:INFECTIOUS DISEASES Keywords:ICU, Acinetobacter, Pseudomonas, Antimicrobial Resistance Published on: 26-Apr-2011, 07:33:49 PM GMT How to cite the article:kart Yasar K, Pehlivanoglu F, Sengoz G. Emerging Antibiotic Resistance in Psedomonas and Acinetobacter Strains Isolated from ICU Patients: Comparison of Years 1999, 2006 and WebmedCentral INFECTIOUS DISEASES 2011;2(4):WMC Source(s) of Funding: No source of funding Competing Interests: No competing interests. Additional Files: Manuscript Title page Webmedcentral > Original Articles Page 1 of 12
2 Emerging Antibiotic Resistance In Psedomonas And Acinetobacter Strains Isolated From ICU Patients: Comparison Of Years 1999, 2006 And 2009 Author(s):Kart Yasar K, Pehlivanoglu F, Sengoz G Abstract Objectives: Pseudomonas and Acinetobacter spp. which are usually resistant to many antibiotics, are the most important infectious pathogens in intensive care units (ICUs). The aim of this study was to determine the antibiotic resistance patterns of these agents and to follow variation in resistance among the years of 1999, 2006 and Methods: The resistance rates of various antibiotics for 21, 38 and 54 acinetobacter and 26, 44 and 66 pseudomonas bacteria which were isolated from blood cultures of ICU patients in years 1999, 2006 and 2009 respectively were compared with Fischer s qui square test statistically. Results: The most effective antibiotics were amikacin (88%), cephaperazone-sulbactam (85%), piperacillin-tazobactam (85%), ceftazidim (75%) and imipenem (75%) for Pseudomonas spp. and imipenem (76%),cephaperazone-sulbactam (71%), ciprofloxacin (52%) and amikacin (48%) for Acinetobacter spp. in Decreasing sensivities to amikacin (76%), cephaperazone-sulbactam (53%), piperacillin-tazobactam (71%), ceftazidim (53%) and imipenem (64%) for Pseudomonas spp. and decreasing sensivities to imipenem (28%), cephaperazone-sulbactam (37%), ciprofloxacin (13%) and amikacin (17%), piperacillin for Acinetobacter spp in 2009 were significant (p<0,05). Conclusions: These results suggested that significant resistance development for imipenem, cephaperazone-sulbactam and ciprofloxacin occurred against acinetobacter strains and for cephaperazone-sulbactam, amikacin and ceftazidime against pseudomonas strains. Increased resistance in our ICU is significant in Acinetobacter spp. The usage of some antibiotics have been limited and multidrug-resistant or pan-resistant strains have been monitorized by infection control committee of our hospital. Protective measures like good hand hygiene, strict contact isolation and control strategies for rational antibiotic usage may be effective factors for infection control caused by these pathogens in ICUs. Introduction Antibiotic-resistant bacteria are an emerging problem in intensive care units (ICUs). Infections caused by multidrug-resistant organisms may result in prolonged hospitalization, increased mortality rates and costs. Pseudomonas aeruginosa is a certain nosocomial pathogen with notable virulence factors and the ability to exhibit antibiotic resistance. Acinetobacter species have been associated with numerous ourbreaks of infection, especially in ICUs (1). Multidrug resistant P.aeruginosa and Acinetobacter species shows an increased risk of infection in patients in ICUs and clonal dissemination of multidrug-resistant strains occurs commonly (1). In addition, Fagon et al (2) reported that pneumonia with Acinetobacter spp. or P.aeruginosa was related with increased mortality rates (40%). Similarly, Blot et al (3) reported a crude hospital mortality rate of 42% for patients with A.baumannii bacteraemia. The use of broad spectrum antibiotics may lead the colonization with these pathogens and consequently to serious infections. The most important determinants for reduction of incidence of infections caused by Pseudomonas and Acinetobacter species in ICUs are rational antibiotic management, investigation of environmental sources of infection and strict contact isolation procedures. Optimizing empirical therapy requires knowledge of antimicrobial resistance patterns. The aim of this study was to determine the antibiotic resistance patterns of Pseudomonas and Acinetobacter species and to follow variation in resistance among the years of 1999, 2006 and Methods Settings Our hospital, is a 550-bed tertiary hospital. The adult internal and surgical ICU was founded with six beds in 1999 and 16 beds were added in There is an Webmedcentral > Original Articles Page 2 of 12
3 infection control committee and with two infection control nurses. The infection control nurses inform and liaise with the ward staff for isolation procedures and infection control measures based on microbiological results. Universal precautions are practiced by all health care workers. Infection control problems are also discussed in clinical meetings. Laboratory procedures The resistance rates of various antibiotics for 21, 38 and 54 acinetobacter and 26, 44 and 66 pseudomonas bacteria which were isolated from blood cultures of ICU patients in years 1999, 2006 and 2009 respectively were compared with Fischer s qui square test statistically. Blood cultures processed by automated BacT/Alert 3D system (Bio Merieux, France) and only one sample was studied from each patient. Positive signaled samples in BacT/Alert were cultured to choclate agar and after hours of incubation at 37 C, suspected colonies for Pseudomonas and Acinetobacter species identified with conventional biochemical procedures. The antimicrobial susceptibilities of ampicillin-sulbactam (SAM), gentamicin (GN), amikacin (AK), ceftriaxone (CRO), ciprofloxacin (CIP), cefoperazone-sulbactam (CFP), meropenem (MEM), piperacillin-tazobactam (TZP), cefepime (FEP) and ceftazidime (CAZ) were investigated by Kirby Bauer disc diffusion method on Mueller Hinton agar plates according to Clinical Laboratory Standard Institution (CLSI) recommendations (4). Results A total of 136 Pseudomonas spp. And 113 Acinetobacter spp. strains were evaluated for susceptibility to different antibiotics i.e. SAM, GN, AK, CRO, CIP, CFP, MEM, TZP, FEP and CAZ. Out of 136 pseudomonas strains, 26 were isolated in 1999, 44 were in 2006 and 66 were in Of all acinetobacter strains, 21 were isolated in 1999, 38 were in 2006 and 54 were in The most effective antibiotics were AK (88%), CFP (85%), TZP (85%), CAZ (75%) and MEM (75%) for Pseudomonas spp. and MEM (76%), CFP (71%), CIP (52%) and AK (48%) for Acinetobacter spp. in (Table 1 and 2). Table 1: Antimicrobial resistance rates of 136 Pseudomonas spp. isolates Table 2: Resistance rates of 113 Acinetobacter spp. isolates Decreasing sensivities to AK (76%), CFP (53%), TZP (71%), CAZ (53%) and MEM (64%) for Pseudomonas spp. in 2009 were significant (p<0,05). For Acinetobacter strains, there were significant decreasing sensivities to MEM (28%), CFP (37%), CIP (13%) and AK (17%), in 2009 too (p<0,05) (Figure 1 and 2). Figure 1. Resistance patterns of Pseudomonas spp. by years 1999, 2006 and Figure 2. Resistance patterns of Acinetobacter spp. by years 1999, 2006 and Discussion Pseudomonas and Acinetobacter species have emerged as the major causes of nosocomial infections, particularly in ICUs. Despite advances in sanitation and hygiene facilities and the introduction of new antimicrobial agents for management of nosocomial infections, Acinetobacter and pseudomonas infections still remains as a major factor related with hospital mortality and threats in critically ill patients. Unfortunately, many of infectious disease physicians have recently been confronted with multidrug-resistant P.aeruginosa and Acinetobacter isolates which are resistant to all beta-lactams and quinolones. In fact, inadequate empirical treatment has been related with mortality exceeding 30% (5) and delays in initiation of appropriate antimicrobial agent contribute prolonged hospitalization and persistence of infection (6). The prediction and selection of appropriate antimicrobials require active surveillance of emerging resistance trends. Obritsch et al (7) reported that significant increase in resistance rates of pseudomonas strains obtained from ICU patients from 1993 to 2002 for ciprofloxacin, imipenem, tobramycin and aztreonam. They also found that multidrug-resistance rates had increased from 4% in 1993 to 14% in Similarly, multi-drug resistant acinetobacter strains have been detected in recent years in our ICU. These multi-drug resistant acinetobacter strains could disseminate after contamination of the hospital environment and by nosocomial transmission especially by the hands of hospital staff among critically ill patients in our ICU. The infection control nurses of our hospital inform and liaise with the ward staff for isolation procedures and infection control measures when multi-drug resistant acineobacter strains isolated in the ICU. These problems are also discussed in clinical meetings. However, dissemination of these pathogens in the ICU could not be prevented despite regular training of personnel, due to inadequate number of staff, frequent staff changes and ward staff with low compliance to the preventive measures for infections in our hospital. Webmedcentral > Original Articles Page 3 of 12
4 Dual resistance rates for beta-lactams and quinolones were the highest among all antibiotics in this study (7). It is noticeable in our study that the sensitivity to quinolones and aminoglycosides also decreased remarkably beside the sensitivity to carbapenem and beta-lactam antibiotics decreased in particularly acinetobacter strains. In a review that analyzed the risk factors associated with development of multi-drug resistant A.baumannii and P.aeruginosa, deficiencies in the implementation of infection control guidelines and the use of broad-spectrum antibiotics were determined to be the most important risk factors (8). It has been found that use of carbapenems and third-generation cephalosporins appear to be associated with the development of an MDR phenotype by A. baumannii, while carbapenems and fluoroquinolones are implicated in MDR P. aeruginosa. As though, the antibiotic treatment is regulated by the infectious disease physicians and use of redundant antibiotics is avoided carefully in our ICU, nevertheless, the decrease in the antibiotic sensitivities of the acinetobacter and pseudomonas strains isolated in our ICU couldn t have been prevented until Beside the use of redundant antibiotics, it has also been demonstrated that the factors associated with patients such as hospitalization at ICU and bad general conditions have been suggested to be the facilitating factors for the resistant acinetobacter infections (9). In the recent years, hospital infections and ICU outbreaks such as primarily VIP due to multi-drug resistant A.baumannii have been reported (10-2). In fact, increased resistance in our ICU is significant in Acinetobacter spp. between years of 1999 and In compliance with our results, there are many reports from Turkey and other countries mentioned about increased antimicrobial resistance in Acinetobacter spp. A.baumannii has been one of the most frequently detected pathogens and the approximately half of the strains were found resistant to carbapenem in a multi-center study that has been conducted in Turkey and that investigated the infectious factors at ICU (13). In the MYSTIC Study that investigated the antimicrobial sensitivities of the nosocomial Gram negative pathogens, the sensitivities of P.aeruginosa strains to ceftazidime, cefepime and tobramycin were found 48%, 41% and 35% respectively, whereas 67% of the A.baumannii strains were found multi-drug resistant and those sensitivities of A.baumannii strains to carbapenem, tobramycin, cefepime, ciprofloxacin and ceftazidime were detected to be 53%, 44%, 37%, 29% and 22%, respectively (14). The resistance change rates of the ICU-sourced P.aeruginosa and A.baumannii strains between the years 2003 to 2006 was analyzed in another study conducted in Turkey and a significant decrease has been found in the sensitivity of the pseudomonas strains to carbapenem, beta-lactam and quinolone. The sensitivity of the A.baumannii isolates to carbapenem, beta-lactam antibiotics, quinolones and aminoglycosides significantly decreased in the year 2006 (15). In a multi-center study performed by participitation of 13 different ICUs that investigated device-associated hospital-acquired infection rates, the resistance rates of the P.aeruginosa strains to ciprofloxacin and ceftazidime, imipenem, piperacillin/tazobactam were found 51%, 38% and 30%, respectively, whereas the resistance rate of A.baumannii to piperacillin/ tazobactam was detected to 87% (16). Also, The 2009 Report of the International Nosocomial Infection Control Consortium (INICC) has reported according to the surveillance results with the participation of 173 ICUs in Latin America, Europe, Asia and Africa that device-associated infection rates were remarkably higher than the US ICU infection rates, rate of imipenem resistant acinetobacter was 46,3% and rate of quinolone-resistant pseudomonas was 50% (17). In another study that analyzed the episodes of the ICU-sourced 96 nosocomial bacteremia developed by A.baumannii, use of central venous catheter and ventilator, previous colonization with A.baumannii, respiratory-cardiovascular deficiency were determined to be a risk factor for A.baumannii bacteremia in univariate analysis. In the multivariate analyses of the same study; previous colonization and cardiovascular deficiency were demonstrated to be independent risk factors. The cumulative survival curves of A.baumannii bacteremia showed no difference when compared with control group, hospitalization duration and cost were found significant (18). In conclusion, resistance development for commonly used antibiotics against acinetobacter and pseudomonas strains in the ICU has been increased between years of 1999 and Increased resistance in our ICU is significant in Acinetobacter spp. Regular surveillance of ICU infections and adopting basic infection control practices that have been shown to prevent healthcare associated infections are very important steps towards the reduction of these infections (16). Improving hand hygiene practices of healthcare workers, strict contact isolation procedures and aceptic care of vascular catheters are important measures to prevent pseudomonas and acinetobacter colonisation and may provide decrease in the incidence of related bacteremia. In addition, there is a need to emphasize on the rational use of antimicrobials and strictly adhere to the concept of reserve drugs to minimize the misuse of available antimicrobials. Therefore, Webmedcentral > Original Articles Page 4 of 12
5 restricted antibiotic policies, antibiotic cycling and shorter antibiotic usage may be effective in reducing antibiotic resistance. References 1. Paterson D. The epidemiological profile of infections with multidrug-resistant Pseudomonas areruginosa and Acinetobacter species. Clin Infect Dis 2006; 43(suppl 2):s Fagon JY, Chastre J, Hance AJ, Montravers P, Novava A, Gibert C. Nosocomial pneumoniae in ventilated patients: a cohort study evaluating attr?butable mortality and hospital stay. Am J Med 1993; 94: Blot S, Vandewwoude K, Colardyn F. Nosocomial bacteremia involving Acinetobacter baumannii in critically ill patients: a matched cohort study. Intensive Care Med 2003; 29: Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility tests, 17th ed, M100-S18. Wayne, PA: CLSI; Ibrahim EH, Sherman G, Ward S, Fraser VJ, Kollef MH. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 2000; 118: Kollef MH. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 1999; 115: Obritsch MD, Fish DN, MacLaren R, Jung R. National surveillance of antimicrobial resistance in Pseudomonas aeruginosa?solates obtained from intensive care unit patients from 1993 to Antimicrob Agents and Chemother 2004; 48: Falagas ME, Kopterides P. Risk factors for the isolation of multi-drug resistant Acinetobacter baumannii and Pseudomonas aeruginosa: a systematic review of the literature. J Hosp Infect 2006;64: Poutanen SM, Louie M, Simor AE. Risk factors, clinical features and outcome of Acinetobacter bacteremia in adults. Eur J Clin Microbiol Dis 1997; 16: Corbella X, Montero A, Pujol M, Dominguez MA, Ayats J, Argerich MJ, et al. Emergence and rapid spread of carbapenem resistance during a large and sustained hospital outbreak of multiresistant Acinetobacter baumannii. J Clin Microbiol 2000;38: Roberts SA, Findlay R, Lang SDR. Investigation of an outbreak of multiüdrug resistant Acinetobacter baumannii in an intensive care burns unit. J Hosp Infect 2001; 48: Aygun G, Demirkiran O, Utku T, Mete B, Urkmez S, Yilmaz M, et al. Environmental contamination of during a carbapenem-resistant an Acinetobacter baumannii outbreak in an intensive care unit. J Hosp Infect 2002; Yucesoy M, Yulug N, Kocagoz S, Unal S, Cetin S, Calangu S, et al. Antimicrobial resistance of gram-negative isolates from intensive care units in Turkey: comparison to previous threevyrars. J Chemother 2000; 12: Zarakolu P, Hascelik G, Unal S. Antimicrobial susceptibility pattern of nosocomial gram negative pathogens: results from MYSTIC study in Hacettepe University Adult Hospital ( ). Mikrobiyol Bul 2006; 40: Aliskan H, Colakoglu S, Turunc T, Demiroglu YZ, Erdogan F, Akin S, et al. Four years of monitoring of antibiotic sensitivity rates of Pseudomonas aeruginosa and Acinetobacter baumannii strains isolated from patients in intensive care unit and inpatient clinics. Mikrobiyol Bul 2008; 42: Leblebicioglu H, Rosenthal VD, Arikan OA, Ozgultekin A, Yalcin AN, Koksal I, et al. Deviceüassociated hospital-acquired infection rates in Turkish intensive care units. Findings of the International Nosocomial Infection Control Concortium (INICC) J Hosp Infect 2007; 65: Rosenthal VD, Maki DG, Jamulitrat S, Mederios E, Kumar Todi S, Gomez DY, et al. International Nosocomial Infection Control Contortium (INICC) report, data summary for , issued June Am J Infect Control 2010; 38: Jang TN, Lee SH, Huang CH, Lee CL, Chen WY. Risk factors and impact of nosocomial Acinetobacter baumannii bloodstream infections in the adult intensive care unit: a case-control study. J Hosp Infect 2009; 73: Webmedcentral > Original Articles Page 5 of 12
6 Illustrations Illustration 1 Table 1: Antimicrobial resistance rates of 136 Pseudomonas spp. isolates Years CN AK CAZ CIP CFP MEM TZP FEP 1999 (n:26) 53 11, ,1 15, ,3 34, (n:44 ) 61,3 31, ,3 18,1 20,4 22,7 29, (n:66) 59,1 24,2 46, ,9 36,4 28,8 45,5 SAM: Ampicillin-sulbactam, CN: gentamicin, AK: amikacin, CIP: ciprofloxacin, CFP: cefoperazone-sulbactam, MEM: meropenem, TZP: piperacillin-tazobactam, FEP: cefepime, CAZ: ceftazidime. Webmedcentral > Original Articles Page 6 of 12
7 Illustration 2 Table 2: Resistance rates of 113 Acinetobacter spp. Isolates Years SAM CN AK CRO CIP CFP MEM TZP FEP 1999 (n:21) 66,6 80,9 52,3 71,4 47,6 28,5 23,8 66, (n:38) 52,6 76,3 55,2 92,1 78,4 23, ,4 42, (n:54) 61 90,7 83,3 94, ,2 90,7 79,6 SAM: Ampicillin-sulbactam, CN: gentamicin, AK: amikacin, CRO: ceftriaxone, CIP: ciprofloxacin, CFP: cefoperazone-sulbactam, MEM: meropenem, TZP: piperacillin-tazobactam, FEP: cefepime, CAZ: ceftazidime. Webmedcentral > Original Articles Page 7 of 12
8 Illustration 3 Figure 1. Resistance patterns of Pseudomonas spp. by years 1999, 2006 and Webmedcentral > Original Articles Page 8 of 12
9 Illustration 4 Figure 2. Resistance patterns of Acinetobacter spp. by years 1999, 2006 and Webmedcentral > Original Articles Page 9 of 12
10 Reviews Review 1 Review Title: Emerging Antibiotic Resistance in Pseudomonas and Acinetobacter Strains Isolated from ICU Patients Posted by Dr. Thomas Herchline on 04 Oct :09:24 PM GMT 1 Is the subject of the article within the scope of the subject category? Yes 2 Are the interpretations / conclusions sound and justified by the data? Yes 3 Is this a new and original contribution? Yes 4 Does this paper exemplify an awareness of other research on the topic? Yes 5 Are structure and length satisfactory? Yes 6 Can you suggest brief additions or amendments or an introductory statement that will increase the value of this paper for an international audience? 7 Can you suggest any reductions in the paper, or deletions of parts? No 8 Is the quality of the diction satisfactory? Yes 9 Are the illustrations and tables necessary and acceptable? Yes 10 Are the references adequate and are they all necessary? Yes 11 Are the keywords and abstract or summary informative? Yes Rating: 4 Comment: This study largely confirms the findings of many other publications on this topic. The tables do not reproduce well in the pdf format. It would be preferred if findings were consistently represented as percent resistant OR percent susceptible. Competing interests: None Invited by the author to make a review on this article? : No Experience and credentials in the specific area of science: Infectious Diseases physician Publications in the same or a related area of science: No How to cite: Herchline T.Emerging Antibiotic Resistance in Pseudomonas and Acinetobacter Strains Isolated from ICU Patients[Review of the article 'Emerging Antibiotic Resistance in Psedomonas and Acinetobacter Strains Isolated from ICU Patients: Comparison of Years 1999, 2006 and 2009 ' by ].WebmedCentral 2011;2(10):WMCRW00988 No Webmedcentral > Original Articles Page 10 of 12
11 Review 2 Review Title: Emerging Antibiotic Resistance in Psedomonas and Acinetobacter Strains Isolated from ICU Patients: Comparison of Years 1999, 2006 and 2009 Posted by Dr. Semsinur Karabela on 09 Jun :15:15 AM GMT 1 Is the subject of the article within the scope of the subject category? Yes 2 Are the interpretations / conclusions sound and justified by the data? Yes 3 Is this a new and original contribution? Yes 4 Does this paper exemplify an awareness of other research on the topic? Yes 5 Are structure and length satisfactory? Yes 6 Can you suggest brief additions or amendments or an introductory statement that will increase the value of this paper for an international audience? 7 Can you suggest any reductions in the paper, or deletions of parts? No 8 Is the quality of the diction satisfactory? Yes 9 Are the illustrations and tables necessary and acceptable? Yes 10 Are the references adequate and are they all necessary? Yes 11 Are the keywords and abstract or summary informative? Yes Rating: 8 Comment: This article is a valuable article that pointed out the emerging antimicrobial resistance of nonfermenters in ICUs. It is important to monitorize the resistance patterns of these agents in ICUs and in hospitals. Competing interests: No Invited by the author to make a review on this article? : Yes Experience and credentials in the specific area of science: Yes. I have a similar study. Publications in the same or a related area of science: Yes References:?eng?z, G.,?. Karabela, Y. Durdu, et al. Determination of isepamicin resistance in Pseudomonas strains and comparison with other aminoglycosides. Klimik Dergisi 2005; 18(1): How to cite: Karabela S.Emerging Antibiotic Resistance in Psedomonas and Acinetobacter Strains Isolated from ICU Patients: Comparison of Years 1999, 2006 and 2009[Review of the article 'Emerging Antibiotic Resistance in Psedomonas and Acinetobacter Strains Isolated from ICU Patients: Comparison of Years 1999, 2006 and 2009 ' by ].WebmedCentral 2011;2(6):WMCRW00813 No Webmedcentral > Original Articles Page 11 of 12
12 Disclaimer This article has been downloaded from WebmedCentral. With our unique author driven post publication peer review, contents posted on this web portal do not undergo any prepublication peer or editorial review. It is completely the responsibility of the authors to ensure not only scientific and ethical standards of the manuscript but also its grammatical accuracy. Authors must ensure that they obtain all the necessary permissions before submitting any information that requires obtaining a consent or approval from a third party. Authors should also ensure not to submit any information which they do not have the copyright of or of which they have transferred the copyrights to a third party. Contents on WebmedCentral are purely for biomedical researchers and scientists. They are not meant to cater to the needs of an individual patient. The web portal or any content(s) therein is neither designed to support, nor replace, the relationship that exists between a patient/site visitor and his/her physician. Your use of the WebmedCentral site and its contents is entirely at your own risk. We do not take any responsibility for any harm that you may suffer or inflict on a third person by following the contents of this website. Webmedcentral > Original Articles Page 12 of 12
Incidence of Strongyle infection in cattle and pig with relevance to rainfall in Meghalaya
Article ID: WMC00889 ISSN 2046-1690 Incidence of Strongyle infection in cattle and pig with relevance to rainfall in Meghalaya Corresponding Author: Dr. Subhasish Bandyopadhyay, Senior Scientist, Eastern
More informationPrevalence of Metallo-Beta-Lactamase Producing Pseudomonas aeruginosa and its antibiogram in a tertiary care centre
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 4 Number 9 (2015) pp. 952-956 http://www.ijcmas.com Original Research Article Prevalence of Metallo-Beta-Lactamase
More informationAppropriate antimicrobial therapy in HAP: What does this mean?
Appropriate antimicrobial therapy in HAP: What does this mean? Jaehee Lee, M.D. Kyungpook National University Hospital, Korea KNUH since 1907 Presentation outline Empiric antimicrobial choice: right spectrum,
More informationAn Approach to Linezolid and Vancomycin against Methicillin Resistant Staphylococcus Aureus
Article ID: WMC00590 ISSN 2046-1690 An Approach to Linezolid and Vancomycin against Methicillin Resistant Staphylococcus Aureus Author(s):Dr. K P Ranjan, Dr. D R Arora, Dr. Neelima Ranjan Corresponding
More informationAntimicrobial stewardship in managing septic patients
Antimicrobial stewardship in managing septic patients November 11, 2017 Samuel L. Aitken, PharmD, BCPS (AQ-ID) Clinical Pharmacy Specialist, Infectious Diseases slaitken@mdanderson.org Conflict of interest
More informationUpdate on Resistance and Epidemiology of Nosocomial Respiratory Pathogens in Asia. Po-Ren Hsueh. National Taiwan University Hospital
Update on Resistance and Epidemiology of Nosocomial Respiratory Pathogens in Asia Po-Ren Hsueh National Taiwan University Hospital Ventilator-associated Pneumonia Microbiological Report Sputum from a
More informationNational Surveillance of Antimicrobial Resistance in Pseudomonas aeruginosa Isolates Obtained from Intensive Care Unit Patients from 1993 to 2002
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Dec. 2004, p. 4606 4610 Vol. 48, No. 12 0066-4804/04/$08.00 0 DOI: 10.1128/AAC.48.12.4606 4610.2004 Copyright 2004, American Society for Microbiology. All Rights
More informationMDR Acinetobacter baumannii. Has the post antibiotic era arrived? Dr. Michael A. Borg Infection Control Dept Mater Dei Hospital Malta
MDR Acinetobacter baumannii Has the post antibiotic era arrived? Dr. Michael A. Borg Infection Control Dept Mater Dei Hospital Malta 1 The Armageddon recipe Transmissible organism with prolonged environmental
More informationSurveillance of Antimicrobial Resistance among Bacterial Pathogens Isolated from Hospitalized Patients at Chiang Mai University Hospital,
Original Article Vol. 28 No. 1 Surveillance of Antimicrobial Resistance:- Chaiwarith R, et al. 3 Surveillance of Antimicrobial Resistance among Bacterial Pathogens Isolated from Hospitalized Patients at
More informationAntimicrobial Cycling. Donald E Low University of Toronto
Antimicrobial Cycling Donald E Low University of Toronto Bad Bugs, No Drugs 1 The Antimicrobial Availability Task Force of the IDSA 1 identified as particularly problematic pathogens A. baumannii and
More informationRISK FACTORS AND CLINICAL OUTCOMES OF MULTIDRUG-RESISTANT ACINETOBACTER BAUMANNII BACTEREMIA AT A UNIVERSITY HOSPITAL IN THAILAND
RISK FACTORS AND CLINICAL OUTCOMES OF MULTIDRUG-RESISTANT ACINETOBACTER BAUMANNII BACTEREMIA AT A UNIVERSITY HOSPITAL IN THAILAND Siriluck Anunnatsiri 1 and Pantipa Tonsawan 2 1 Division of Infectious
More informationSepsis is the most common cause of death in
ADDRESSING ANTIMICROBIAL RESISTANCE IN THE INTENSIVE CARE UNIT * John P. Quinn, MD ABSTRACT Two of the more common strategies for optimizing antimicrobial therapy in the intensive care unit (ICU) are antibiotic
More informationPrevalenceofAntimicrobialResistanceamongGramNegativeIsolatesinanAdultIntensiveCareUnitataTertiaryCareCenterinSaudiArabia
: K Interdisciplinary Volume 17 Issue 4 Version 1.0 Year 2017 Type: Double Blind Peer Reviewed International Research Journal Publisher: Global Journals Inc. (USA) Online ISSN: 2249-4618 & Print ISSN:
More informationNosocomial Infections: What Are the Unmet Needs
Nosocomial Infections: What Are the Unmet Needs Jean Chastre, MD Service de Réanimation Médicale Hôpital Pitié-Salpêtrière, AP-HP, Université Pierre et Marie Curie, Paris 6, France www.reamedpitie.com
More informationOriginal Articles. K A M S W Gunarathne 1, M Akbar 2, K Karunarathne 3, JRS de Silva 4. Sri Lanka Journal of Child Health, 2011; 40(4):
Original Articles Analysis of blood/tracheal culture results to assess common pathogens and pattern of antibiotic resistance at medical intensive care unit, Lady Ridgeway Hospital for Children K A M S
More informationAcinetobacter species-associated infections and their antibiotic susceptibility profiles in Malaysia.
Biomedical Research 12; 23 (4): 571-575 ISSN 97-938X Scientific Publishers of India Acinetobacter species-associated infections and their antibiotic susceptibility profiles in Malaysia. Nazmul MHM, Jamal
More informationAntimicrobial Stewardship/Statewide Antibiogram. Felicia Matthews Senior Consultant, Pharmacy Specialty BD MedMined Services
Antimicrobial Stewardship/Statewide Antibiogram Felicia Matthews Senior Consultant, Pharmacy Specialty BD MedMined Services Disclosures Employee of BD Corporation MedMined Services Agenda CMS and JCAHO
More informationWhat does multiresistance actually mean? Yohei Doi, MD, PhD University of Pittsburgh
What does multiresistance actually mean? Yohei Doi, MD, PhD University of Pittsburgh Disclosures Merck Research grant Clinical context of multiresistance Resistance to more classes of agents Less options
More informationOther Enterobacteriaceae
GUIDE TO INFECTION CONTROL IN THE HOSPITAL CHAPTER NUMBER 50: Other Enterobacteriaceae Author Kalisvar Marimuthu, MD Chapter Editor Michelle Doll, MD, MPH Topic Outline Topic outline - Key Issues Known
More informationAerobic bacterial infections in a burns unit of Sassoon General Hospital, Pune
Original article Aerobic bacterial infections in a burns unit of Sassoon General Hospital, Pune Patil P, Joshi S, Bharadwaj R. Department of Microbiology, B.J. Medical College, Pune, India. Corresponding
More informationInt.J.Curr.Microbiol.App.Sci (2017) 6(3):
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 6 Number 3 (2017) pp. 891-895 Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/10.20546/ijcmas.2017.603.104
More informationConcise Antibiogram Toolkit Background
Background This toolkit is designed to guide nursing homes in creating their own antibiograms, an important tool for guiding empiric antimicrobial therapy. Information about antibiograms and instructions
More informationThe International Collaborative Conference in Clinical Microbiology & Infectious Diseases
The International Collaborative Conference in Clinical Microbiology & Infectious Diseases PLUS: Antimicrobial stewardship in hospitals: Improving outcomes through better education and implementation of
More informationDR. MICHAEL A. BORG DIRECTOR OF INFECTION PREVENTION & CONTROL MATER DEI HOSPITAL - MALTA
DR. MICHAEL A. BORG DIRECTOR OF INFECTION PREVENTION & CONTROL MATER DEI HOSPITAL - MALTA The good old days The dread (of) infections that used to rage through the whole communities is muted Their retreat
More informationDefining Extended Spectrum b-lactamases: Implications of Minimum Inhibitory Concentration- Based Screening Versus Clavulanate Confirmation Testing
Infect Dis Ther (2015) 4:513 518 DOI 10.1007/s40121-015-0094-6 BRIEF REPORT Defining Extended Spectrum b-lactamases: Implications of Minimum Inhibitory Concentration- Based Screening Versus Clavulanate
More informationOutline. Antimicrobial resistance. Antimicrobial resistance in gram negative bacilli. % susceptibility 7/11/2010
Multi-Drug Resistant Organisms Is Combination Therapy the Way to Go? Sutthiporn Pattharachayakul, PharmD Prince of Songkhla University, Thailand Outline Prevalence of anti-microbial resistance in Acinetobacter
More informationLack of Change in Susceptibility of Pseudomonas aeruginosa in a Pediatric Hospital Despite Marked Changes in Antibiotic Utilization
Infect Dis Ther (2014) 3:55 59 DOI 10.1007/s40121-014-0028-8 BRIEF REPORT Lack of Change in Susceptibility of Pseudomonas aeruginosa in a Pediatric Hospital Despite Marked Changes in Antibiotic Utilization
More informationGENERAL NOTES: 2016 site of infection type of organism location of the patient
GENERAL NOTES: This is a summary of the antibiotic sensitivity profile of clinical isolates recovered at AIIMS Bhopal Hospital during the year 2016. However, for organisms in which < 30 isolates were recovered
More informationPrevalence and Resistance pattern of Pseudomonas strains isolated from ICU Patients
ISSN: 2319-7706 Volume 3 Number 3 (2014) pp. 527-534 http://www.ijcmas.com Original Research Article Prevalence and Resistance pattern of Pseudomonas strains isolated from ICU Patients T.Raakhee 1 * and
More informationSustaining an Antimicrobial Stewardship
Sustaining an Antimicrobial Stewardship Much needless expense, untoward effect, harm and disappointment can be prevented by better judgment in the use of antimicrobials Whitney A. Jones, PharmD Antimicrobial
More informationInternational Journal of Research in Pharmacology & Pharmacotherapeutics
International Journal of Research in Pharmacology & Pharmacotherapeutics ISSN Print: 2278 2648 IJRPP Vol.3 Issue 3 July-Sep-214 ISSN Online: 2278-2656 Journal Home page: Research article Open Access Study
More informationMulti-drug resistant Acinetobacter (MDRA) Surveillance and Control. Alison Holmes
Multi-drug resistant Acinetobacter (MDRA) Surveillance and Control Alison Holmes The organism and it s epidemiology Surveillance Control What is it? What is it? What is it? What is it? Acinetobacter :
More informationAntibiotic utilization and Pseudomonas aeruginosa resistance in intensive care units
NEW MICROBIOLOGICA, 34, 291-298, 2011 Antibiotic utilization and Pseudomonas aeruginosa resistance in intensive care units Vladimíra Vojtová 1, Milan Kolář 2, Kristýna Hricová 2, Radek Uvízl 3, Jan Neiser
More informationInternational Journal of Health Sciences and Research ISSN:
International Journal of Health Sciences and Research www.ijhsr.org ISSN: 2249-9571 Original Research Article Antibiotic Susceptibility Pattern of Pseudomonas Aeruginosa Isolated From Various Clinical
More informationManagement of Hospital-acquired Pneumonia
Management of Hospital-acquired Pneumonia Adel Alothman, MB, FRCPC, FACP Asst. Professor, COM, KSAU-HS Head, Infectious Diseases, Department of Medicine King Abdulaziz Medical City Riyadh Saudi Arabia
More informationSafe Patient Care Keeping our Residents Safe Use Standard Precautions for ALL Residents at ALL times
Safe Patient Care Keeping our Residents Safe 2016 Use Standard Precautions for ALL Residents at ALL times #safepatientcare Do bugs need drugs? Dr Deirdre O Brien Consultant Microbiologist Mercy University
More informationComparison of Antibiotic Resistance and Sensitivity with Reference to Ages of Elders
Daffodil International University Institutional Repository DIU Journal of Science and Technology Volume 10, Issue 1-2, July 2015 2016-06-16 Comparison of Antibiotic Resistance and Sensitivity with Reference
More informationThe importance of infection control in the era of multi drug resistance
Dr. Kumar Consultant Infectious Diseases Physician Hospital Sungai buloh The importance of infection control in the era of multi drug resistance Nosocomial infections In Australian acute hospitals 200,000
More informationPrevalence of Extended Spectrum Beta- Lactamase Producers among Various Clinical Samples in a Tertiary Care Hospital: Kurnool District, India
International Journal of Current Microbiology and Applied Sciences ISSN: 319-77 Volume Number (17) pp. 57-3 Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/1.5/ijcmas.17..31
More informationESBL Producers An Increasing Problem: An Overview Of An Underrated Threat
ESBL Producers An Increasing Problem: An Overview Of An Underrated Threat Hicham Ezzat Professor of Microbiology and Immunology Cairo University Introduction 1 Since the 1980s there have been dramatic
More informationUnderstanding the Hospital Antibiogram
Understanding the Hospital Antibiogram Sharon Erdman, PharmD Clinical Professor Purdue University College of Pharmacy Infectious Diseases Clinical Pharmacist Eskenazi Health 5 Understanding the Hospital
More informationMulti-Drug Resistant Gram Negative Organisms POLICY REVIEW DATE EXTENDED Printed copies must not be considered the definitive version
Multi-Drug Resistant Gram Negative Organisms POLICY REVIEW DATE EXTENDED 2018 Printed copies must not be considered the definitive version DOCUMENT CONTROL POLICY NO. IC-122 Policy Group Infection Control
More information4/3/2017 CLINICAL PEARLS: UPDATES IN THE MANAGEMENT OF NOSOCOMIAL PNEUMONIA DISCLOSURE LEARNING OBJECTIVES
CLINICAL PEARLS: UPDATES IN THE MANAGEMENT OF NOSOCOMIAL PNEUMONIA BILLIE BARTEL, PHARMD, BCCCP APRIL 7 TH, 2017 DISCLOSURE I have had no financial relationship over the past 12 months with any commercial
More informationLearning Points. Raymond Blum, M.D. Antimicrobial resistance among gram-negative pathogens is increasing
Raymond Blum, M.D. Learning Points Antimicrobial resistance among gram-negative pathogens is increasing Infection with antimicrobial-resistant pathogens is associated with increased mortality, length of
More informationPrevalence of Gastrointestinal Parasite in Goats in Shillong, Meghalaya, India
Article ID: WMC00777 ISSN 2046-1690 Prevalence of Gastrointestinal Parasite in Goats in Shillong, Meghalaya, India Author(s):Dr. Subhasish Bandyopadhyay, Mrs. Pallabi Devi, Dr. Asit Bera, Dr. Samiran Bandyopadhyay,
More informationCystic Fibrosis- management of Burkholderia. cepacia complex infections
Guideline Cystic Fibrosis- management of Burkholderia cepacia complex infections Key messages Burkholderia cepacia infections are associated with significant adverse outcomes in Cystic Fibrosis patients
More informationDetection and Quantitation of the Etiologic Agents of Ventilator Associated Pneumonia in Endotracheal Tube Aspirates From Patients in Iran
Letter to the Editor Detection and Quantitation of the Etiologic Agents of Ventilator Associated Pneumonia in Endotracheal Tube Aspirates From Patients in Iran Mohammad Rahbar, PhD; Massoud Hajia, PhD
More informationAntimicrobial Susceptibility Patterns
Antimicrobial Susceptibility Patterns KNH SURGERY Department Masika M.M. Department of Medical Microbiology, UoN Medicines & Therapeutics Committee, KNH Outline Methodology Overall KNH data Surgery department
More informationMono- versus Bitherapy for Management of HAP/VAP in the ICU
Mono- versus Bitherapy for Management of HAP/VAP in the ICU Jean Chastre, www.reamedpitie.com Conflicts of interest: Consulting or Lecture fees: Nektar-Bayer, Pfizer, Brahms, Sanofi- Aventis, Janssen-Cilag,
More informationNew Drugs for Bad Bugs- Statewide Antibiogram
New Drugs for Bad Bugs- Statewide Antibiogram Felicia Matthews, Pharm.D., BCPS Senior Consultant, Pharmacy Specialty BE MedMined Services Disclosures Employee of BD Corporation MedMined Services Agenda
More informationFighting MDR Pathogens in the ICU
Fighting MDR Pathogens in the ICU Dr. Murat Akova Hacettepe University School of Medicine, Department of Infectious Diseases, Ankara, Turkey 1 50.000 deaths each year in US and Europe due to antimicrobial
More information2012 ANTIBIOGRAM. Central Zone Former DTHR Sites. Department of Pathology and Laboratory Medicine
2012 ANTIBIOGRAM Central Zone Former DTHR Sites Department of Pathology and Laboratory Medicine Medically Relevant Pathogens Based on Gram Morphology Gram-negative Bacilli Lactose Fermenters Non-lactose
More informationInternational Journal of Pharma and Bio Sciences ANTIMICROBIAL SUSCEPTIBILITY PATTERN OF ESBL PRODUCING GRAM NEGATIVE BACILLI ABSTRACT
Research Article Microbiology International Journal of Pharma and Bio Sciences ISSN 0975-6299 ANTIMICROBIAL SUSCEPTIBILITY PATTERN OF ESBL PRODUCING GRAM NEGATIVE BACILLI * PRABHAKAR C MAILAPUR, DEEPA
More informationDoes Screening for MRSA Colonization Have A Role In Healthcare-Associated Infection Prevention Programs?
Does Screening for MRSA Colonization Have A Role In Healthcare-Associated Infection Prevention Programs? John A. Jernigan, MD, MS Division of Healthcare Quality Promotion Centers for Disease Control and
More informationAntimicrobial Resistance Surveillance from sentinel public hospitals, South Africa, 2013
Antimicrobial Resistance Surveillance from sentinel public s, South Africa, 213 Authors: Olga Perovic 1,2, Melony Fortuin-de Smidt 1, and Verushka Chetty 1 1 National Institute for Communicable Diseases
More informationMultidrug-Resistant Organisms: How Do We Define them? How do We Stop Them?
Multidrug-Resistant Organisms: How Do We Define them? How do We Stop Them? Roberta B. Carey, PhD Centers for Disease Control and Prevention Division of Healthcare Quality Promotion Why worry? MDROs Clinical
More informationBacterial Pathogens in Urinary Tract Infection and Antibiotic Susceptibility Pattern from a Teaching Hospital, Bengaluru, India
ISSN: 2319-7706 Volume 4 Number 11 (2015) pp. 731-736 http://www.ijcmas.com Original Research Article Bacterial Pathogens in Urinary Tract Infection and Antibiotic Susceptibility Pattern from a Teaching
More informationWitchcraft for Gram negatives
Witchcraft for Gram negatives Dr Subramanian S MD DNB MNAMS AB (Medicine, Infect Dis) Infectious Diseases Consultant Global Health City, Chennai www.asksubra.com Drug resistance follows the drug like a
More informationAntimicrobial Stewardship Strategy: Antibiograms
Antimicrobial Stewardship Strategy: Antibiograms A summary of the cumulative susceptibility of bacterial isolates to formulary antibiotics in a given institution or region. Its main functions are to guide
More informationAntimicrobial Susceptibility Patterns of Salmonella Typhi From Kigali,
In the name of God Shiraz E-Medical Journal Vol. 11, No. 3, July 2010 http://semj.sums.ac.ir/vol11/jul2010/88030.htm Antimicrobial Susceptibility Patterns of Salmonella Typhi From Kigali, Rwanda. Ashok
More informationAcinetobacter Resistance in Turkish Tertiary Care Hospitals. Zeliha KOCAK TUFAN, MD, Assoc. Prof.
Acinetobacter Resistance in Turkish Tertiary Care Hospitals Zeliha KOCAK TUFAN, MD, Assoc. Prof. Acinetobacter Problem Countries that have reported hospital outbreaks of carbapenem-resistant Acinetobacter
More informationIntrinsic, implied and default resistance
Appendix A Intrinsic, implied and default resistance Magiorakos et al. [1] and CLSI [2] are our primary sources of information on intrinsic resistance. Sanford et al. [3] and Gilbert et al. [4] have been
More informationEARS Net Report, Quarter
EARS Net Report, Quarter 4 213 March 214 Key Points for 213* Escherichia coli: The proportion of patients with invasive infections caused by E. coli producing extended spectrum β lactamases (ESBLs) increased
More informationMulti-drug resistant microorganisms
Multi-drug resistant microorganisms Arzu TOPELI Director of MICU Hacettepe University Faculty of Medicine, Ankara-Turkey Council Member of WFSICCM Deaths in the US declined by 220 per 100,000 with the
More informationESBL- and carbapenemase-producing microorganisms; state of the art. Laurent POIREL
ESBL- and carbapenemase-producing microorganisms; state of the art Laurent POIREL Medical and Molecular Microbiology Unit Dept of Medicine University of Fribourg Switzerland INSERM U914 «Emerging Resistance
More informationEscalating Problem on Pseudomonas and Acinobacter Resistance and MDRO
Escalating Problem on Pseudomonas and Acinobacter Resistance and MDRO Kuntaman Department of Medical Microbiology, Faculty of Medicine Airlangga University / Dr.Soetomo Hospital Surabaya 08113410352 kuntaman@mitra.net.id
More informationCollecting and Interpreting Stewardship Data: Breakout Session
Collecting and Interpreting Stewardship Data: Breakout Session Michael S. Calderwood, MD, MPH Regional Hospital Epidemiologist, Dartmouth-Hitchcock Medical Center March 20, 2019 None Disclosures Outline
More informationDissecting the epidemiology of resistant Enterobacteriaceae and non-fermenters
Dissecting the epidemiology of resistant Enterobacteriaceae and non-fermenters Jon Otter, PhD Centre for Clinical Infection and Diagnostics Research (CIDR), King's College London & Guy's and St. Thomas'
More informationa. 379 laboratories provided quantitative results, e.g (DD method) to 35.4% (MIC method) of all participants; see Table 2.
AND QUANTITATIVE PRECISION (SAMPLE UR-01, 2017) Background and Plan of Analysis Sample UR-01 (2017) was sent to API participants as a simulated urine culture for recognition of a significant pathogen colony
More informationFlorida Health Care Association District 2 January 13, 2015 A.C. Burke, MA, CIC
Florida Health Care Association District 2 January 13, 2015 A.C. Burke, MA, CIC 11/20/2014 1 To describe carbapenem-resistant Enterobacteriaceae. To identify laboratory detection standards for carbapenem-resistant
More informationKonsequenzen für Bevölkerung und Gesundheitssysteme. Stephan Harbarth Infection Control Program
Konsequenzen für Bevölkerung und Gesundheitssysteme Stephan Harbarth Infection Control Program University of Geneva Hospitals Outline Introduction What data sources are available? AMR-associated outcomes
More informationMultidrug-Resistant Acinetobacter
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 6 Number 9 (2017) pp. 1598-1603 Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/10.20546/ijcmas.2017.609.196
More informationAvailable online at ISSN No:
Available online at www.ijmrhs.com ISSN No: 2319-5886 International Journal of Medical Research & Health Sciences, 2017, 6(4): 36-42 Comparative Evaluation of In-Vitro Doripenem Susceptibility with Other
More informationRecommendations for Implementation of Antimicrobial Stewardship Restrictive Interventions in Acute Hospitals in Ireland
Recommendations for Implementation of Antimicrobial Stewardship Restrictive Interventions in Acute Hospitals in Ireland A report by the Hospital Antimicrobial Stewardship Working Group, a subgroup of the
More informationAntibiotic usage in nosocomial infections in hospitals. Dr. Birgit Ross Hospital Hygiene University Hospital Essen
Antibiotic usage in nosocomial infections in hospitals Dr. Birgit Ross Hospital Hygiene University Hospital Essen Infection control in healthcare settings - Isolation - Hand Hygiene - Environmental Hygiene
More informationRelationship Between Antibiotic Consumption and Resistance in European Hospitals
Relationship Between Antibiotic Consumption and Resistance in European Hospitals Dominique L. Monnet National Center for Antimicrobials and Infection Control, Statens Serum Institut, Copenhague, Danemark
More informationBACTERIOLOGICALL STUDY OF MICROORGANISMS ON MOBILES AND STETHOSCOPES USED BY HEALTH CARE WORKERS IN EMERGENCY AND ICU S
Research Article Harika A,, 2013; Volume 2(3): 290-297 ISSN: 2277-8713 BACTERIOLOGICALL STUDY OF MICROORGANISMS ON MOBILES AND STETHOSCOPES USED BY HEALTH CARE WORKERS IN EMERGENCY AND ICU S HARIKAA A,
More informationSuccessful stewardship in hospital settings
Successful stewardship in hospital settings Pr Charles-Edouard Luyt Service de Réanimation Institut de Cardiologie Groupe Hospitalier Pitié-Salpêtrière Université Pierre et Marie Curie, Paris 6 www.reamedpitie.com
More informationThe Basics: Using CLSI Antimicrobial Susceptibility Testing Standards
The Basics: Using CLSI Antimicrobial Susceptibility Testing Standards Janet A. Hindler, MCLS, MT(ASCP) UCLA Health System Los Angeles, California, USA jhindler@ucla.edu 1 Learning Objectives Describe information
More informationAntimicrobial Susceptibility Profile of E. coli Isolates Causing Urosepsis: Single Centre Experience
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 7 Number 05 (2018) Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/10.20546/ijcmas.2018.705.298
More informationDetection of ESBL Producing Gram Negative Uropathogens and their Antibiotic Resistance Pattern from a Tertiary Care Centre, Bengaluru, India
ISSN: 2319-7706 Volume 4 Number 12 (2015) pp. 578-583 http://www.ijcmas.com Original Research Article Detection of ESBL Producing Gram Negative Uropathogens and their Antibiotic Resistance Pattern from
More informationAntibiotic susceptibility pattern of Pseudomonas aeruginosa at the tertiary care center, Dhiraj Hospital, Piparia, Gujarat
Original Research Article Antibiotic susceptibility pattern of Pseudomonas aeruginosa at the tertiary care center, Dhiraj Hospital, Piparia, Gujarat Sonal Lakum 1*, Anita 1, Himani Pandya 2, Krunal Shah
More informationUsing Web-Based Instruction Modules to Improve Practitioner Knowledge at Yale New Haven Hospital on the Prevention of Antimicrobial Resistance and
Using Web-Based Instruction Modules to Improve Practitioner Knowledge at Yale New Haven Hospital on the Prevention of Antimicrobial Resistance and Health-Care Associated Infections Overall Goals & Objectives:
More informationAntimicrobial Stewardship
Antimicrobial Stewardship Report: 11 th August 2016 Issue: As part of ensuring compliance with the National Safety and Quality Health Service Standards (NSQHS), Yea & District Memorial Hospital is required
More information(DRAFT) RECOMMENDATIONS FOR THE CONTROL OF MULTI-DRUG RESISTANT GRAM-NEGATIVES: CARBAPENEM RESISTANT ENTEROBACTERIACEAE
(DRAFT) RECOMMENDATIONS FOR THE CONTROL OF MULTI-DRUG RESISTANT GRAM-NEGATIVES: CARBAPENEM RESISTANT ENTEROBACTERIACEAE John Ferguson (Hunter New England, NSW) on behalf of MRGN Task Force Acknowledgement
More informationReceived: February 29, 2008 Revised: July 22, 2008 Accepted: August 4, 2008
J Microbiol Immunol Infect. 29;42:317-323 In vitro susceptibilities of aerobic and facultative anaerobic Gram-negative bacilli isolated from patients with intra-abdominal infections at a medical center
More informationDetecting / Reporting Resistance in Nonfastidious GNR Part #2. Janet A. Hindler, MCLS MT(ASCP)
Detecting / Reporting Resistance in Nonfastidious GNR Part #2 Janet A. Hindler, MCLS MT(ASCP) Methods Described in CLSI M100-S21 for Testing non-enterobacteriaceae Organism Disk Diffusion MIC P. aeruginosa
More informationDrive More Efficient Clinical Action by Streamlining the Interpretation of Test Results
White Paper: Templated Report Comments Drive More Efficient Clinical Action by Streamlining the Interpretation of Test Results Background The availability of rapid, multiplexed technologies for the comprehensive
More informationCONSUMPTION OF ANTIMICROBIAL DRUGS AND ANTIBIOTIC RESISTANCE IN PROBLEMATIC FOR HOSPITAL INFECTIOUS PATHOLOGY BACTERIA
Trakia Journal of Sciences, No 4, pp 338-342, 2013 Copyright 2013 Trakia University Available online at: http://www.uni-sz.bg ISSN 1313-7050 (print) ISSN 1313-3551 (online) Original Contribution CONSUMPTION
More informationAerobic Bacterial Profile and Antimicrobial Susceptibility Pattern of Pus Isolates in a Tertiary Care Hospital in Hadoti Region
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 6 Number 5 (2017) pp. 2866-2873 Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/10.20546/ijcmas.2017.605.326
More information03/09/2014. Infection Prevention and Control A Foundation Course. Talk outline
Infection Prevention and Control A Foundation Course 2014 What is healthcare-associated infection (HCAI), antimicrobial resistance (AMR) and multi-drug resistant organisms (MDROs)? Why we should be worried?
More informationSummary of the latest data on antibiotic resistance in the European Union
Summary of the latest data on antibiotic resistance in the European Union EARS-Net surveillance data November 2017 For most bacteria reported to the European Antimicrobial Resistance Surveillance Network
More informationMeasure Information Form
Release Notes: Measure Information Form Version 3.0b **NQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE** Measure Set: Pneumonia (PN) Performance Measure Identifier: Measure Information Form
More informationBacterial etiology of bloodstream infections and antimicrobial resistance in Dhaka, Bangladesh,
Ahmed et al. Antimicrobial Resistance and Infection Control (2017) 6:2 DOI 10.1186/s13756-016-0162-z RESEARCH Open Access Bacterial etiology of bloodstream infections and antimicrobial resistance in Dhaka,
More informationJournal of Antimicrobial Chemotherapy Advance Access published April 14, 2008
Journal of Antimicrobial Chemotherapy Advance Access published April 14, 2008 Journal of Antimicrobial Chemotherapy doi:10.1093/jac/dkn164 Control of extended-spectrum b-lactamase-producing Klebsiella
More informationTreatment Guidelines and Outcomes of Hospital- Acquired and Ventilator-Associated Pneumonia
SUPPLEMENT ARTICLE Treatment Guidelines and Outcomes of Hospital- Acquired and Ventilator-Associated Pneumonia Antoni Torres, Miquel Ferrer, and Joan Ramón Badia Pneumology Department, Clinic Institute
More informationNational Clinical Guideline Centre Pneumonia Diagnosis and management of community- and hospital-acquired pneumonia in adults
National Clinical Guideline Centre Antibiotic classifications Pneumonia Diagnosis and management of community- and hospital-acquired pneumonia in adults Clinical guideline 191 Appendix N 3 December 2014
More informationWorkplan on Antibiotic Usage Management
IMPACT Forum: Antibiotic Guideline in Perspective Workplan on Antibiotic Usage Management Dr. Raymond Yung Consultant Microbiologist PYNEH 20 April 2002 May 2002 Dr. Raymond Yung 1 Objective 1. Heighten
More informationAntibiotic stewardship in long term care
Antibiotic stewardship in long term care Shira Doron, MD Associate Professor of Medicine Division of Geographic Medicine and Infectious Diseases Tufts Medical Center Boston, MA Consultant to Massachusetts
More informationTaiwan Crit. Care Med.2009;10: %
2008 30% 2008 2008 2004 813 386 07-346-8339 E-mail srwann@vghks.gov.tw 66 30% 2008 1 2008 2008 Intensive Care Med (2008)34:17-60 67 2 3 C activated protein C 4 5,6 65% JAMA 1995;273(2):117-23 Circulation,
More information